155 related articles for article (PubMed ID: 35492876)
1. Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.
Bikorimana JP; Salame N; Beaudoin S; Balood M; Crosson T; Abusarah J; Talbot S; Löbenberg R; Plouffe S; Rafei M
Cell Rep Med; 2022 Mar; 3(3):100534. PubMed ID: 35492876
[TBL] [Abstract][Full Text] [Related]
2. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
3. An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
Bikorimana JP; Abusarah J; Gonçalves M; Farah R; Saad W; Talbot S; Stanga D; Beaudoin S; Plouffe S; Rafei M
Cancer Sci; 2024 Apr; 115(4):1102-1113. PubMed ID: 38287511
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of accutox
Bikorimana JP; El-Hachem N; Abusarah J; Gonçalves MP; Farah R; Mandl GA; Talbot S; Beaudoin S; Stanga D; Plouffe S; Rafei M
J Transl Med; 2024 Jun; 22(1):532. PubMed ID: 38831284
[TBL] [Abstract][Full Text] [Related]
6. Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation.
Pei M; Xu R; Zhang C; Wang X; Li C; Hu Y
Colloids Surf B Biointerfaces; 2021 Jan; 197():111378. PubMed ID: 33010719
[TBL] [Abstract][Full Text] [Related]
7. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
8. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
9. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
[TBL] [Abstract][Full Text] [Related]
10. Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells.
Lee W; Kingstad-Bakke B; Paulson B; Larsen A; Overmyer K; Marinaik CB; Dulli K; Toy R; Vogel G; Mueller KP; Tweed K; Walsh AJ; Russell J; Saha K; Reyes L; Skala MC; Sauer JD; Shayakhmetov DM; Coon J; Roy K; Suresh M
PLoS Pathog; 2021 Jan; 17(1):e1009168. PubMed ID: 33444400
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
12. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
13. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
14. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
[TBL] [Abstract][Full Text] [Related]
15. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
[TBL] [Abstract][Full Text] [Related]
16. TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.
Damo M; Wilson DS; Simeoni E; Hubbell JA
Sci Rep; 2015 Dec; 5():17622. PubMed ID: 26631690
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
18. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
19. Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4
Yang L; Bracho-Sanchez E; Fernando LP; Lewis JS; Carstens MR; Duvall CL; Keselowsky BG
Bioeng Transl Med; 2017 Jun; 2(2):202-211. PubMed ID: 29313030
[TBL] [Abstract][Full Text] [Related]
20. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]